Why is Shire stock closer to its 52 week low than to its 52 week high?

Quote
anonymous said:
So true,and I don't understand it. How can our sales force be ranked last ? I better pick up the pace or else my manager said I'll be on a plan.
Click to expand...

Fact: Shire NBU ranked in top 10% of sales forces in the U.S. according to fiercepharma and other outlets. Numbers agree as 515 reps do over $2.5 Billion in Sales.

Fact: Fleming listed as worst CEO in industry according to Fiercepharma, Glassdoor, and other outlets.

Fact: You are a booty sniffer and You don't work here. Listen close.... your mom is calling. She just finished making your PB&J sandwich for lunch for your unemployed @$$
 












anonymous said:
Fact: Shire NBU ranked in top 10% of sales forces in the U.S. according to fiercepharma and other outlets. Numbers agree as 515 reps do over $2.5 Billion in Sales.

Fact: Fleming listed as worst CEO in industry according to Fiercepharma, Glassdoor, and other outlets.

Fact: You are a booty sniffer and You don't work here. Listen close.... your mom is calling. She just finished making your PB&J sandwich for lunch for your unemployed @$$
Click to expand...

#1. True
#2. True
#3. Can't be positive but sounds like it could be true
 






will someone please post the link to this "alleged" fierce pharma article that states Shire reps are the worst in the industry. I've looked and cant find anything so I'm calling that statement total BS...unless someone can post.
 






anonymous said:
Fact: Shire NBU ranked in top 10% of sales forces in the U.S. according to fiercepharma and other outlets. Numbers agree as 515 reps do over $2.5 Billion in Sales.

Fact: Fleming listed as worst CEO in industry according to Fiercepharma, Glassdoor, and other outlets.

Fact: You are a booty sniffer and You don't work here. Listen close.... your mom is calling. She just finished making your PB&J sandwich for lunch for your unemployed @$$
Click to expand...


Fact: Flem fired you.
 






anonymous said:
Fact: Flem fired you.
Click to expand...

Wrong. Been with Shire 2 CEO's before this disaster came to Shire and I will be with Shire after he resigns (he will resign instead of getting Fired) U r in the small minority and must be related to Flem if u think the company has done well under his direction. He has been a disaster and that is a nice description.
 






At least once a week a doctor or a rep from another company will ask what the hell is going on over there at Shire. It used to be such a respected and admired company before Fleming and Perry came over. I strongly believe that it can become that again once those 2 are shown the door.
 












If you want to understand our stock price, you just have to look at and compare our US stock ownership vs. peers. Nasdaq makes this information public.

Shire has a paltry 21% of equity owned by institutional investors (glaringly low), compared to Biogen's 89% and Alexion's 95% institutional ownership.

Why such a huge difference? Institutional investors who listen to our CEO very carefully and analyze our corporate performance and outlook versus expectations set by management have been dumping our stock and putting their money behind other companies.

In the last reporting period, Shire had 49 new institutional investors and lost 95 institutional investors (who sold out their positions completely). In other words, 2 institutional investors left Shire for every one new institutional investor that came in.

By comparison, Biogen had 90 new and 74 sold out, and Alexion had 87 new and 49 sold out. Unlike us, these companies are gaining more institutional investors than they are losing.

Institutional investors are dumping Shire 2:1 while buying companies like Biogen and Alexion instead.

If you want to see it all for yourself, go to this link for Shire and type in other ticker symbols for comparison: http://www.nasdaq.com/symbol/shpg/institutional-holdings
 






anonymous said:
If you want to understand our stock price, you just have to look at and compare our US stock ownership vs. peers. Nasdaq makes this information public.

Shire has a paltry 21% of equity owned by institutional investors (glaringly low), compared to Biogen's 89% and Alexion's 95% institutional ownership.

Why such a huge difference? Institutional investors who listen to our CEO very carefully and analyze our corporate performance and outlook versus expectations set by management have been dumping our stock and putting their money behind other companies.

In the last reporting period, Shire had 49 new institutional investors and lost 95 institutional investors (who sold out their positions completely). In other words, 2 institutional investors left Shire for every one new institutional investor that came in.

By comparison, Biogen had 90 new and 74 sold out, and Alexion had 87 new and 49 sold out. Unlike us, these companies are gaining more institutional investors than they are losing.

Institutional investors are dumping Shire 2:1 while buying companies like Biogen and Alexion instead.

If you want to see it all for yourself, go to this link for Shire and type in other ticker symbols for comparison: http://www.nasdaq.com/symbol/shpg/institutional-holdings
Click to expand...
Great points! Thanks for posting. I guess we should probably follow them and dump the stock too.
 






anonymous said:
If you want to understand our stock price, you just have to look at and compare our US stock ownership vs. peers. Nasdaq makes this information public.

Shire has a paltry 21% of equity owned by institutional investors (glaringly low), compared to Biogen's 89% and Alexion's 95% institutional ownership.

Why such a huge difference? Institutional investors who listen to our CEO very carefully and analyze our corporate performance and outlook versus expectations set by management have been dumping our stock and putting their money behind other companies.

In the last reporting period, Shire had 49 new institutional investors and lost 95 institutional investors (who sold out their positions completely). In other words, 2 institutional investors left Shire for every one new institutional investor that came in.

By comparison, Biogen had 90 new and 74 sold out, and Alexion had 87 new and 49 sold out. Unlike us, these companies are gaining more institutional investors than they are losing.

Institutional investors are dumping Shire 2:1 while buying companies like Biogen and Alexion instead.

If you want to see it all for yourself, go to this link for Shire and type in other ticker symbols for comparison: http://www.nasdaq.com/symbol/shpg/institutional-holdings
Click to expand...

Stocks up and making nice gains google BOY.
 












Stock is down because the market is not confident that the orphan drug act will remain in place as it is. Shire is far too dependent on government dollars from the orphan drug act ——Trump could reverse orphan drug act tomorrow.
Someone needs to ask Shire how much of their rare disease business is dependent on government dollars.

The answer would be too much. Thus the stock will not recover anytime soon.
 






anonymous said:
Stock is down because the market is not confident that the orphan drug act will remain in place as it is. Shire is far too dependent on government dollars from the orphan drug act ——Trump could reverse orphan drug act tomorrow.
Someone needs to ask Shire how much of their rare disease business is dependent on government dollars.

The answer would be too much. Thus the stock will not recover anytime soon.
Click to expand...
SELL, SELL, SELL, SELL, SELL
 












anonymous said:
BUY, BUY, BUY, BUY
Click to expand...


Worst post in cp history. Sux your in so deep sell when it comes up if u listened to me last time it was available tom dump you would have switched all your Shire to Apple straight up b cause they were both 160. U sat which is why u r begging people to buy this crap. Your desperate. Valeant territory on the horizon.
 






What’s up with Shire? Stock still stock at $147. Are they having a temporary setback? Look at all the drug company 52 week highs today!

AbbVie hit another 52 week high today and closed at $123! (AbbVie employees are getting rich!)
Pfizer even hit a 52 week high today and closed at $39!
Novartis hit another 52 week high today, closing at 93!
Even Amgen, which does not have its earnings call til next week hit a 52 week high today, closing at $196!
Biogen hit a 52 week high today, closing at $367!
 












Because the CEO tied an anchor to the stock price with the Baxalta deal and NBU uncertainty. This stock is dead until the NBU announcement is decided. Flemming has been an absolute disaster. How him and his band of thieves have kept their jobs is just ridiculous.
 






Stock down again today to $146.93 where peers are hitting 52 week highs and creating tons of value. What the hell is causing Shire’s lag?

Baxter hit another 52 week high today, closing at $72.05!
Pfizer hit another 52 week high today, closing at$39.02!
Amgen is rocketing ahead of its earnings call this week. It hit another 52 week high today and closed at $198!
 






Top Bottom
Back
Quote